Place ofcromoglicate acid in clinical practice



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

According to the statistics data about 40% of the population of the world suffer from allergic diseases. A variety of the factors participate in activation and formation of allergic illnesses, assume the use of a wide spectrum of medical products for correction and changes arising at an allergic inflammation. It is necessary to note that a basis of treatment of these diseases is preventive maintenance. We will stop in detail at the group of preparations of cromoglicate acid, which is widely used in clinical practice for prevention of exacebrations and treatment of allergic diseases. Some features of cromons such as a high profile ofsafety, good tolerance, possibility of long using in pediatrics and during pregnancy, low system bioavailability and economic advisability will be discussed.

About the authors

N V Shartanova

N V Shartanova

References

  1. Глобальная стратегия лечения и профилактики бронхиальной астмы. Пересмотр 2006 год. Под ред. А.Г. Чучалина. М., «Атмосфера». 2007. с. 104-110.
  2. Kerem E. et al. Predicting the need for hospitalization in children with acute asthma. Chest., USA. 1990, p. 1205-1304.
  3. Федосеев Г.Б., Трофимов В.И. Бронхиальная астма. «Нордмедиздат». СПб., 2006, с. 112-132.
  4. Apter A. et al. Asthma in the elderly: a brief report. N. Engl. Reg. Allergy Proc. 1988, p. 153-155.
  5. Клиническая аллергология. Рук-во для практических врачей. Под редакцией акад. РАМН P.M. Хаитова. М., «МЕДпресс-информ». 2002, с. 245-254.
  6. Белоусов Ю.Б., Моисеев В.С., Лепахин В.К. Клиническая фармакология и фармакотерапия. Рук-во для врачей. М., 1997, с. 270-273.
  7. Powell H., Gibson P.G. Inhaled corticosteroid doses in asthma: an evidence-based approach. Med. J., Australia. 2003, p. 223-225
  8. Dahlen B., Nizankowska E., Szczeklik A. et al. Benefits from adding the 5-lipoxygenase inhibitor zileiton to conventional therapy in aspirin-intolerant asthmatics. Am. J. Respir. Crit. Care Med. 1998, p. 1187-1194.
  9. Howell J.B.L., Altounyan R.E.C. A doudle-blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet. 1967, p.539-541.
  10. Stevens M.T., Edwards AM., Howell J.B. Sodium cromoglicate: an ineffective drug or meta-analysis misused? Pharm. Stat., USA. 2007, p.141-142.
  11. Yoshihara S., Kanno N., Yamada Y et al. Arisaka O. Effects of early intervention with inhaled sodium cromoglycate in childhood asthma. Medline, Japan. 2006, p. 63-72.
  12. Guevara J.P., Ducharme F.M., Keren R. et al. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma. USA, Pubmed. 2006, p.215-216.
  13. SanoY, Adachi M., Kiuchi T., Miyamoto T. Effects of nebulized sodium cromoglycate on adult patients with severe refractory asthma. Ann. Allergy Asthma Immunol, Japan. 2006, p. 420-433.
  14. Yoshida S., Amayasu H., Sakamoto H. et al. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Ann. Allergy Asthma Immunol. Japan. 1998, p.171-173.
  15. Hidari K.I., Tsujii E., Hiroi J. et al. In vitro and in vivo inhibitory effects of disodium cromoglycate on influenza virus infection. Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences, Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation, Pubmed, Yada, Japan. 2004, p. 825-828.
  16. Miyatake A., Fujita M., Nagasaka Y. et al. The new role of disodium cromoglycate in the treatment of adults with bronchial asthma. Pubmed., Japan. 2007, p. 231-233.
  17. Yamazaki T., Yamaguchi T., Sasaki N. et al. The inhibitory effect of disodium cromoglycate on the growth of Chlamydophila (Chlamydia) pneumoniae in vitro. Pediatric Pulmonol., Japan. 2006, p. 799-800.
  18. Распопина Н.А., Шутинин И.О. Образовательная программа по бронхиальной астме при беременности. М., 2004, с. 5-7.
  19. Anderson S.D. Single-dose agents in the prevention of exercise-induced asthma: a descriptive review. PubMed, Medline, Australia. 2004, p. 365-367.
  20. Patel K.R. Sodium cromoglycate and verapamil alone and in combination in exercise induced asthma. Br. Med. J. (Clin. Res. Ed.), Philadelphia. 1983, p. 286-287.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright © Pharmarus Print Media, 2009



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies